Clinical Trial Update: Anifrolumab for Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 trial investigating anifrolumab for hidradenitis suppurativa is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Anifrolumab (anifrolumab)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Hidradenitis Suppurativa, Acne Inversa | Phase 2 | Status: ACTIVE_NOT_RECRUITING